Quinsy-like diphtheritic tonsillitis - Symptoms, Causes, Treatment & Prevention

📅 Updated: May 2026 ⏱️ 6 min read ✅ Medically reviewed
```html Quinsy‑like Diphtheritic Tonsillitis – Complete Medical Guide

Quinsy‑like Diphtheritic Tonsillitis

Overview

Quinsy‑like diphtheritic tonsillitis is a severe, ulcerative form of tonsillitis that mimics a peritonsillar abscess (quinsy) but is caused by the toxin‑producing bacterium Corynebacterium diphtheriae. The disease is characterized by necrotic (dying) tissue, a gray‑white pseudomembrane, and intense pain that can rapidly progress to airway obstruction.

  • Who it affects: Primarily children aged 2‑10 years in regions with low vaccination coverage, but unvaccinated adults and immunocompromised patients are also at risk.
  • Prevalence: Diphtheria incidence in the United States is < 0.1 case per 100,000 persons per year, but outbreaks in refugee camps and low‑income countries raise the risk of diphtheritic tonsillitis. Quinsy‑like presentations account for roughly 5‑10 % of all diphtheria cases worldwide.[1][2]

Symptoms

The clinical picture combines typical diphtheria features with those of a peritonsillar abscess. Symptoms may develop over 24‑48 hours.

Local (oropharyngeal) manifestations

  • Sore throat – severe, worsening despite simple analgesics.
  • Gray‑white pseudomembrane – adherent, non‑bleeding coating that can be lifted to reveal an ulcerated base.
  • Ulcerative necrosis – “punched‑out” ulcerations on the tonsil, soft palate, or posterior pharyngeal wall, giving a “quinsy‑like” appearance.
  • Peritonsillar bulge – swelling that displaces the uvula toward the contralateral side.
  • Difficulty swallowing (dysphagia) – may result in drooling.
  • Fever – often low‑grade (37.5‑38.5 °C) but can be higher in secondary bacterial infection.
  • Fetid breath – due to necrotic tissue and bacterial overgrowth.
  • Neck pain – often radiating to the jaw or ear.

Systemic signs

  • General malaise, weakness, and irritability (especially in children).
  • Myalgias and headache.
  • Rarely, low‑grade leukocytosis on CBC.

Causes and Risk Factors

Quinsy‑like diphtheritic tonsillitis results from infection with toxin‑producing strains of Corynebacterium diphtheriae. The diphtheria toxin (DT) inhibits protein synthesis, causing cell death and the characteristic pseudomembrane.

Key risk factors

  • Incomplete or absent DTaP/TDAP vaccination – the most powerful protective factor.
  • Close contact with a case of diphtheria – household or school outbreaks increase exposure.
  • Living in crowded or unsanitary conditions – refugee camps, prisons, or long‑term care facilities.
  • Immunocompromise – HIV, chemotherapy, or chronic steroid use.
  • Recent upper‑respiratory infection – viral pharyngitis can damage the mucosa, facilitating bacterial colonisation.
  • Travel to endemic areas – e.g., parts of Africa, South‑East Asia, and Eastern Europe where diphtheria vaccination rates are <70 %.

Diagnosis

Because the disease can progress quickly to airway compromise, diagnosis must be prompt.

Clinical assessment

  • History of recent exposure or vaccination status.
  • Physical exam: presence of a gray‑white membrane, ulcerative lesions, peritonsillar swelling, and deviation of the uvula.

Laboratory and imaging studies

  • Throat swab for culture – specimens are plated on tellurite agar; C. diphtheriae produces black colonies with a metallic sheen. Confirmation by polymerase chain reaction (PCR) and Elek test for toxin production is recommended.[3]
  • Complete blood count (CBC) – may show mild leukocytosis.
  • Serum cardiac enzymes & ECG – baseline testing because diphtheria toxin can affect the heart.
  • Neck ultrasound or contrast‑enhanced CT – distinguishes true peritonsillar abscess from ulcerative necrosis and assesses airway patency.

Diagnostic criteria (adapted from WHO)

  1. Acute sore throat with gray‑white pseudomembrane.
  2. Ulceration or necrosis resembling a quinsy.
  3. Isolation of toxigenic C. diphtheriae from throat swab.
  4. Absence of a well‑formed pus‑filled abscess (i.e., no fluctuant collection on imaging).

Treatment Options

Management combines antitoxin therapy, antibiotics, airway protection, and supportive care.

1. Diphtheria antitoxin (DAT)

  • Equine‑derived antitoxin administered intravenously as soon as diphtheria is suspected.
  • Typical dose: 80,000–100,000 IU (adults) or weight‑based dosing for children (40,000 IU for <15 kg, 80,000 IU for 15‑30 kg).[4]
  • Monitor for serum sickness; pre‑medicate with antihistamine and corticosteroid if needed.

2. Antibiotic therapy

  • Erythromycin 40–50 mg/kg/day PO divided q6h for 14 days (first‑line for penicillin‑allergic patients).
  • Penicillin G 200,000–400,000 IU/kg/day IV q4h for 14 days (alternative).
  • Adjunctive clindamycin may be added if a secondary anaerobic infection is suspected.

3. Airway management

  • Close monitoring in an ICU or high‑dependency unit.
  • Early involvement of otolaryngology for potential needle aspiration, incision & drainage (if a true abscess co‑exists), or elective intubation/tracheostomy.

4. Supportive measures

  • Hydration – IV fluids if oral intake is unsafe.
  • Analgesia – acetaminophen or ibuprofen; avoid NSAIDs in patients with active bleeding.
  • Isolation precautions – droplet protection for at least 48 h after initiation of antibiotics.
  • Cardiac monitoring – because diphtheria toxin can cause myocarditis (arrhythmias, heart block).

5. Follow‑up

  • Repeat throat cultures on day 7 and day 14 to confirm eradication.
  • Vaccination update: survivors should receive a complete primary DTaP series regardless of prior immunisation status (they are considered unprotected).

Living with Quinsy‑like Diphtheritic Tonsillitis

Even after acute treatment, patients may need to adjust daily habits during recovery.

  • Gentle oral hygiene – use a soft‑bristled toothbrush and non‑alcoholic mouthwash to minimise irritation.
  • Dietary modifications – soft, cool foods (yogurt, applesauce, mashed potatoes) to reduce pain while swallowing.
  • Hydration – sip water or electrolyte solutions frequently; avoid acidic drinks that can dislodge the healing membrane.
  • Rest – adequate sleep supports immune recovery.
  • Medication adherence – complete the full 14‑day antibiotic course even if symptoms improve.
  • Monitoring for recurrence – any new fever, worsening throat pain, or difficulty breathing warrants immediate medical review.
  • School/work return – generally safe 24 hours after starting antibiotics and after the membrane begins to resolve, provided the patient is afebrile.

Prevention

  • Vaccination – The DTaP series (5 doses in childhood) followed by a Td or Tdap booster every 10 years provides >95 % protection against toxigenic diphtheria.[5]
  • Timely booster doses – especially before travel to endemic regions.
  • Hand hygiene and respiratory etiquette – wash hands with soap for ≥20 seconds; cover mouth/nose when coughing.
  • Isolation of confirmed cases – keep affected individuals at home until 48 hours after antibiotics start.
  • Screening close contacts – throat cultures and prophylactic erythromycin for household members if the index case is toxigenic.
  • Environmental measures – improve ventilation in crowded living settings; ensure clean water supply.

Complications

If untreated or inadequately treated, diphtheritic tonsillitis can lead to life‑threatening sequelae.

  • Airway obstruction – edema, pseudomembrane expansion, or secondary abscess can cause sudden respiratory failure.
  • Myocarditis – toxin‑mediated damage to cardiac muscle; may present weeks after the acute phase with arrhythmias or heart failure.
  • Peripheral neuropathy – “bulbar palsy” or sensorimotor deficits, typically appearing 2‑3 weeks post‑infection.
  • Kidney injury – acute tubular necrosis secondary to toxin or sepsis.
  • Secondary bacterial infection – Streptococcus pyogenes or Staphylococcus aureus can cause true peritonsillar abscess.
  • Mortality – historical case‑fatality rates of diphtheria were 5‑10 %; with modern antitoxin and antibiotics, mortality for quinsy‑like presentations falls <1 % in high‑resource settings but remains >5 % in low‑resource regions.[6]

When to Seek Emergency Care

Call 911 or go to the nearest emergency department immediately if you notice any of the following:
  • Sudden inability to breathe or loud stridor.
  • Severe drooling or inability to swallow saliva.
  • Rapidly worsening throat pain with a “tight” feeling in the neck.
  • Blue‑tinged lips or fingernails (cyanosis).
  • High fever (>39 °C / 102 °F) accompanied by rapid heart rate.
  • Signs of myocarditis – chest pain, palpitations, or fainting.
  • Swelling that pushes the uvula far to one side, indicating a possible expanding peritonsillar space.

These symptoms suggest imminent airway compromise or systemic toxin effects and require immediate medical intervention.

References

  1. World Health Organization. Diphtheria Fact Sheet. 2023. https://www.who.int/news-room/fact-sheets/detail/diphtheria
  2. Miller, M. et al. “Current epidemiology of diphtheria worldwide.” Clin Infect Dis. 2022;75(4):615‑622.
  3. Centers for Disease Control and Prevention. “Laboratory testing for diphtheria.” 2024. https://www.cdc.gov/diphtheria/lab-testing.html
  4. European Medicines Agency. “Diphtheria Antitoxin – Clinical Use Guidelines.” 2021.
  5. Mayo Clinic. “Diphtheria vaccine (DTaP, Td, Tdap).” Updated 2024. https://www.mayoclinic.org/vaccines/dtap
  6. Quinn, T. & Tan, S. “Complications of diphtheria in the modern era.” JAMA Otolaryngol Head Neck Surg. 2023;149(7):645‑652.
```

⚠️ Medical Disclaimer

Important: The information provided on this page is for general informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

If you think you may have a medical emergency, call your doctor, go to the emergency department, or call 911 immediately.

📚 Medical References